boronophenylalanine-fructose complex
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 1996 (NCT00002781)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiodepletion
Radiodepletion
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- boronophenylalanine-fructose complex
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00085059 | Phase 2 | Apr 1, 2004 | European Organisation for Research and Treatment of Cancer, University of Duisburg-Essen |
| NCT00062348 | Phase 1 | Apr 1, 2003 | European Organisation for Research and Treatment of Cancer, University of Duisburg-Essen |
| NCT00039572 | Phase 1/Phase 2 (Phase 2) | May 1, 2002 | Harvard University, National Cancer Institute (NCI) |
| NCT00002781 | Phase 1 | Apr 1, 1996 | Harvard University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Organisation for Research and Treatment of Cancer | Academic/Hospital | 2 | 2 | 2 | 2003 |
| Harvard University | Academic/Hospital | 2 | 2 | 2 | 1996 |
| University of Duisburg-Essen | Academic/Hospital | 2 | 0 | 2 | 2003 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2002 |
4 organizations
Page 1 / 1